Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Balsalazide sodium enteroclyster and its preparing method

A technology of balsalazide sodium and enema, which is applied in the field of medicine, can solve the problems of limited anal access depth, complicated packaging, and large toxic and side effects, and achieve the effects of increasing residence time, increasing adhesion, and good stability

Active Publication Date: 2009-03-18
SHANXI ZHENDONG ANXIN BIOLOGICAL PHARM CO LTD
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although this method solves the problem of stability and packaging, in addition to adding multiple antioxidants such as sodium disulfide and titanium dioxide, complexing agent EDTA, preservative sodium benzoate, acid-base balance agent sodium dihydrogen sulfate are also added. , and sodium hydroxide, etc.
In addition, the packaging of various liquid enemas is complicated, so the price is expensive. For example, in 2006, the price of Salofalk enema 4g / 60ml X7 imported from Germany was 1476 yuan, and the daily cost of using it on patients was as high as 220 yuan; Although 5-ASA suppositories or sulfasalazine suppositories, the prodrug of 5-ASA, are cheaper, they have a limited anal access depth, and have poor curative effects on other types of UC except rectal UC.
Oral administration of 5-ASA prodrugs such as sulfasalazine or olsalazide has good curative effect but severe side effects; oral administration of 5-ASA prodrug balsalazide has a significant effect on left and distal UC. Good curative effect and less side effects, but the dose is relatively large (6.75g / day abroad, 6.0g / day domestically), and the cost is also high

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0013] Crush 400g of balsalazide sodium, 20g of xanthan gum and 10g of pectin, sieve them, mix them evenly, divide them into sterilized medical rubber enemas, and seal them to obtain the product.

Embodiment 2

[0015] Crush and sieve balsalazide sodium 300g, xanthan gum 150g and pectin 75g, mix evenly, pack in sterilized medical rubber enemas, seal, and obtain.

Embodiment 3

[0017] 1200g of balsalazide sodium, 37.5g of xanthan gum and 12.5g of pectin were crushed and sieved, mixed evenly, divided into sterilized medical rubber enemas, and sealed to obtain the product.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

the invention relates to a Balsalazide disodium enteroclyster which is prepared from the following ingredients (by weight portions): Balsalazide disodium 1-18, xanthan gum 0.125-2.25, pectin 0.0625-1.25. The invention also provides the process for preparing the enteroclyster which contains no anti-oxidant agent, complexing agent, preservative agent and acid-base balancing agent, thereby has better stability.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a balsalazide sodium enema and a preparation method thereof. Background technique [0002] An American research report showed that in ulcerative colitis (UC), total colitis (total colitis) accounted for 37%, left-side colitis (left-side colitis) accounted for 17%, and proctosigmoidotis (proctosigmoidotis) accounted for 46%. According to statistics in Japanese literature, pancolitis accounts for 35%, left-sided colitis accounts for 35%, rectal colitis accounts for 25%, and right-sided or regional colitis accounts for only 5%. Worldwide, nearly 90% of UC patients are mild or moderate UC, and more than 2 / 3 of them involve the colon from the distal end to the splenic flexure. It can be seen that it is of great significance to find effective rectal drug and therapy for left or distal UC. [0003] For the above-mentioned common left colon and distal UC, various oral 5-aminosalicylic acid (5-...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/00A61K31/195A61P1/04
Inventor 李世荣姚娟娟王金生穆清苏杨坚吴月侠
Owner SHANXI ZHENDONG ANXIN BIOLOGICAL PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products